您好,欢迎访问三七文档
当前位置:首页 > 医学/心理学 > 药学 > 国际精神药理学规则系统(IPAP)-广泛性焦虑障碍(GAD
IPAPAlgorithmforGeneralizedAnxietyDisorder(GAD)!#$%&'()*+(IPAP)-,-./012(GAD)34562006.11.16=578789:;,-./012(GAD)=?@ABCDEFGHCIJKLM=NOP/0QRSTU.VWQXYZ[W\]^!1IX_!`2a@5-6%bGADCcd@efghiQjklmIX_/012nopW\QqrstuvVbwx%&IO&yz={|B}~Q%j,-bdGAD y)(1)!%&(theBritishAssociationofPsychopharmacology-BAP)()3(2)!!`O(theNationalInstituteofClinicalExcellence-NICE)()(3)D#$W'(theWorldFederationofSocietiesofBiologicalPsychiatry-WFSBP)=/0QM.12Q12=%& y)4(4)!lmI/0`p ¡¢(theInternationalExpertConsensusGrouponDepressionandAnxiety)=,-./012p )5(5)£¤¥)(theCanadianGuidelines)6I(6)¦§¨©ª«()*+theSouthAfricanPrimaryCareAlgorithms(http¬//)b®)¯f5°±² y{|Q³´ASµ¶· y¸¹=º»bwx()*+z=GAD y)¼@½³Q¾¿ÀÁ]¿±²SGAD%& y()*+bGADn y¶·ÃÄÅ¥Æ:% ykO&Ç ybÈÉÅT¶·pÊËÌ=yÂÍÎÏÐ{Q]ÑÒÓÔ´Õ7bÖchlordiazepoxidePdiazepam]1950×ØÙ1960רÚÛÜÝQGAD(KxÞ@/0$ßàqh)=%& yáâ×SãäåæçèÆ%b80×éQêë5ìíîï1aðfñÄòóbuspirone=ÚÛQ%& yÚS¸ôõb90×éQölmó÷XR5ìíîï%Ï,øÌQs@dù yGAD=Sµ%búû=)ëüý=%þMKIX_Æ%=ÿ!ËÌb¿%&'()*+|W#,pW$%,{|&'(LOE;Õn()%),IyÂ* y¸¹QÊ+jº»K,-.:pWQ/0QÖ123Q45Ì; y67.89I:; y;=g-.×[8=%ËÌO&Ç yI%ó?@)bk¿ÆAQÀÁBC=DS()*+@12(PTSD)=%&'()*+(8P)b]()*+=EFGQÀÁHÌIJ(K=()*+=L¶zQMN)=OPPQ(TheAppraisalofGuidelinesResearchandIPAPAlgorithmforGeneralizedAnxietyDisorder(GAD))QK*()*+RI=STQwUQn(VW=XÛQYZ.Q[\.Qc].QÌ.QI^_=`C.)b!#GAD$%&'()*+,-./0123456789!/0:;=?@)%1¬GAD=abcndeX_#$W'=abfGAD]Fg25×=hgib®hgjkI#$%&'=ôõ10QÊ+jËB%&'()*+=Jl~obfNQ@m7noÀÁppqrstÏËÌ=DSM=uvb7#$%&'=wlQ]GADa xúür=ôõRU.QyzQ{JKLM=NOs@dù=|OabUbSKxabU=“#$¢sñÄ”Aölmó=yÂ}æçèÆ%@~10b]DSMIIIQGADúr=hi@jk/0=Ö$ßQò*+QIX_=ef.hib®hi](2)3AæçèÆ%=yÂ}ölmó@Q Rölmó(imipramineQtrazodone)]8+=yÂHkæçèÆ%10bS®KxÏ?@GAD=WMQd]|DSMIIIRIV=UÏÆefg12bGADúDSMIIIQÏ?@ST/0.ibabrhiÙ´SQÓÆ#=Æ:9(9PÔrs=QCÕ8 ñ,9.¡);Ö$ߢÚ(£Q¤¥¦§QOòF¨)Q/0=©(AdeôDGª=NOPÔ«¬-]®¯ôDð±/0)QI²³.Fok´µ(¯R¶·¸¹P-.=])bGAD=ab]DSMIIIrº»¼p=½I#$12QGADϾ@°RST¿l12b]DSMKuvQabUhÀÁÂQÃGADùÄϾ@RSTrstuvÅ=12bc1@2004×^!#$W'(AmericanPsychiatricAssociation,Washington,DC,2004)“abk+ÆÇȬ#$12”ÉuÊË(DiagnosticandstatisticalManualforMentalDisorders,4thedition,TextRevision(DSMIV-TR)IÌD¢Í“!VWÄÆ”Éâu(theInternationalClassificationforDisease,10thedition(ICD10),Geneva:WorldHealthOrganization)=GADabU.IPAPAlgorithmforGeneralizedAnxietyDisorder(GAD)(GAD)DSMIV.ICD10JKLMÎÏ*ÐÎÏ^ÑÎÏÒÓDSMIV300.02a)yz=/0PNOQhiÙ´6b)JKLM=NOc)Ù´K,6Thi=3T¬ÔÔÔQÕÖ×QØÙÚÄÛQÜÝQ9QÞ0ßàd)/0PNOÔäåDST/0efg12e)hirstu= áqÅ/f)hiÓ§âS4(N#$E.4Q%)8SãefVW(Näiåþq¢Ú)æÙICD10F41.1a) QÔäåde$=çè( “ ”)b)rhi 9Q£QéêQOëQxìÔíQîïÀWGc) DSMIV-TR#JKN*OPQ#RSHITUVWX(DiagnosticandstatisticalManualforMentalDisorders,4thedition,TextRevision)YICD10#Z[\];^T_V(theInternationalClassificationforDisease,10thedition)kICD10fQDSMIVrÙ´6=WGP3T(W#QÃICD10iðef.W#bd=ñ{6|áòóôõDSMIV=abU(]â®ö÷,QDSMIII8IIIR)QÀÁ¾¿ÌDSMIVL@¿()*+=|b ÀÁj¾ øDSMIV=GADabUÃqFlªù11Q12b¾¿]ËÌ¿()*++QVúAhiûüQ ¼wÔô]øabU=[8qýöþ0Qÿ!#ËÌDSM=Ubn($]s×VQGAD=YZ[W\]ST3a@4.1ø6.6%Q12[W\a]1.1ø3.6%2Q13-15b45-55%×&¢[W\úoQ'.[W\@(.=Å)14-16b]×VQS*+°GADRúCÕ=/012QV[W\@10.2%17b]¨©ª«,yÝæQGADCÌICDUabQRúCÕ=/012QV[W\@8%18bGAD[8C-a.g/,D19QoJl[8GAD=fM÷X@o20bGAD[8ppFlËÌ,y01QfN2a-,Q34QabIÑ5678Q%9IPAPAlgorithmforGeneralizedAnxietyDisorder(GAD):;;b]¨©ª«Q/012flm12iÜÏaQ°n23%=/012P56%=lm12qÏ=Ð b?T@ÀAB8¾C([8Q`DsúQEQP,yªFGªV)HÃqË yG;hÀIJ21bGAD=WGppU.QKa+[8L[n10×KxW#=ÓÔ´ÕbÈÉGADjnÃqÖô.MQ¥[8=WGNOJP.|DSMIIIRUab=GADQ5×Öô.M\Ôø40%22bGADkX_½I12YZpW\HF90%QXklm12YZpW\@60%16bnQRc6QGAD±v.kX_U.,'VWA23b)%2¬?STab=OPGADCkX_#$I,'VWpWQW#Ã@pWæÙb¨a+OPn(pW,ÚUVr=Ñ56IfZ78Qº»äiåQäiWåQXY-.QKIZ-[¶P\]%Q^_¾Q`#QPX_4=ËÌbGADCkX_,'VWpWbMNQCastillo;+°2440%=a[8nÆGADW#Q27%bcGAD=abUb]d¡e[8QGAD=[W\@10.2%25bGAD[8fgh[W\j6t~£26b=NSteini27QGAD=efhiNÕÖ×QOëQjQklFl,9.¡Q/0QQ9QKIoXmQYnWQOoW=]pË[8qr-,b#$W'¶s=Qablm12Qtö×12Q`#PX_4ËÌ12QX_/012QÖ1U@QØÙÚ³uvò12(ADHD),12(PTSD)(Cnefghi,²wFojCÕGAD)28b]Qab+þ012IZ-Wxn!A[8WöI¬=Imb!y#$%&z'()*+ôdAGAD,%-.y/012345678,aF299Kessler:/A;GAD=?@ABCò78:DEFGHIJ.yFG,KL'MN»{309AbpWab#$I,'pWÃËGAD=abP yhÀIJbKQ|}Z-[8=Wx,KIÚUVr=Ñ56IfZ78bab y/~=OPqþ0CÕpWQfNlm12`#ËÌ12Qt12QIâ®ÎÏab=4.VWQN3Ä(äiå;)IOVWb|DSMIVUFQNoGADW#°ôDö×12(8t)Q`=GADab)ÔsCbÉÃQZimmermanôdT (*Óñ{6|=bGADhi°ålm12kGADhiÔålm12f+QÅ8]J¶sÆAQÔÊGADhi=lm1231býSéölmóQNS®.5ìíîïülMó(SSRI)5-íîï/gäxåCülMó(SNRI)AGADPlm12nÐ{yÂQ¾¿GADPlm12pW+Q_Á@K%bÈÉÅ8 yBQÙùÍ yGADklm12pW=IPAPAlgorithmforGeneralizedAnxietyDisorder(GAD).+°bS*Avenlafaxineó=á¥5zÄ(posthoc)32Q33ôdXAGADPlm12=tüab}óinyÂbX_=j]xö÷,ËÌölmó(Nmirtazapine)34b]S y§lm12=¡yv(X87%[8nGAD)QchromiumpicolinateA¯fyvInGAD=Äyv}ói@nÂ35bAnlmhi=
本文标题:国际精神药理学规则系统(IPAP)-广泛性焦虑障碍(GAD
链接地址:https://www.777doc.com/doc-359684 .html